April 16, 2021
Hani Kushlaf, MD, presented findings on a new treatment for Pompe disease, a rare neuromuscular disease, virtually at the American Academy of Neurology on April 17.
March 9, 2021
University of Cincinnati researchers have discovered that cooperation between two key genes drive cancer growth, spread and treatment resistance in one particularly aggressive type of breast cancer. The good news is, though, with this knowledge, they can continue to aim their targeted treatments at these genes, singularly and together, to stop breast cancer in its tracks.
March 28, 2022
The University of Cincinnati's Daniel Woo and colleagues recently published a paper in JAMA revealing new insights on how different risk factors following intracerebral hemorrhages can affect patient outcomes.
October 25, 2021
The University of Cincinnati's Dr. Xiaoting Zhang has been awarded a patent for a novel RNA nanoparticle treatment for breast cancer.
October 11, 2021
The University of Cincinnati is opening a new clinical trial looking to see how the combination of immunotherapy and transplant can improve patient outcomes.
November 29, 2021
University of Cincinnati's Dr. Robert Van Haren recently published new research that shows lung cancer surgery outcomes between former and current smokers are similar enough that smoking should not be a barrier to offering surgery.
January 4, 2022
The University of Cincinnati's Dr. Ishita Basu is researching how targeted electrical stimulation can be used as a treatment for mental health disorders.
September 30, 2021
University of Cincinnati researchers have joined a nationwide clinical trial exploring the effectiveness of personalized treatments for patients with acute myelogenous leukemia (AML), a cancer of the blood and bone marrow.
November 16, 2021
Researchers at the University of Cincinnati are leading the largest-ever NIH stroke recovery study, examining if certain biomarkers can help predict patient recovery.
December 9, 2021
University of Cincinnati researchers are leading the FASTEST global trial that will examine the effectiveness of a new treatment for strokes due to intracerebral hemorrhage.